SCHEMBL9953365

SCHEMBL9953365

CCOc1ccc(S(=O)(=O)Cl)cc1NC(C)=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
ALDH1A1 P00352 6/20 0.56
MAPT P10636 3/20 0.56
RORC P51449 1/20 0.51
KMT2A Q03164 4/20 0.49
GAA P10253 2/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 2/20 0.49
EPHX1 P07099 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
LMNA P02545 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
NPC1 O15118 1/20 0.46
MITF O75030 1/20 0.46
THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1553581 0.84 KMT2A (0.63) ALDH1A1MAPTKMT2AMEN1LMNA
SCHEMBL14805391 0.81 TP53 (0.49) CYP1A2CYP2C19ALDH1A1MAPTKMT2A
SCHEMBL1976549 0.80 ALDH1A1 (0.51) ALDH1A1MAPTKMT2AKDM4EMEN1
SCHEMBL24254516 0.80 KMT2A (0.51) CYP1A2CYP2C9CYP2C19ALDH1A1KMT2A
SCHEMBL3687471 0.79 KDM4E (0.50) ALDH1A1GAAKDM4ESMN1; SMN2
SCHEMBL14098226 0.78 CYP1A2 (0.65) CYP1A2CYP2C9CYP2C19ALDH1A1MAPT
SCHEMBL10874979 0.78 TDP1 (0.70) CYP1A2CYP2C9CYP2C19ALDH1A1MAPT
SCHEMBL9182141 0.78 EPHX1 (0.74) CYP1A2CYP2C9CYP2C19ALDH1A1MAPT
SCHEMBL2564265 0.77 ALDH1A1 (0.47) CYP1A2CYP2C9CYP2C19ALDH1A1MAPT
SCHEMBL5256278 0.77 CYP1A2 (0.63) CYP1A2CYP2C9CYP2C19ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed